The JWST Galactic Center Survey -- A White PaperR. Schöedel, Daryl Haggard, John Bally et al.|Liverpool John Moores University|2023Cited by 5
Bevacizumab (B) and erlotinib (E) as first-line therapy in metastatic nonsquamous non-small cell lung cancer (NSCLC) followed by platinum-based chemotherapy (CT) at disease progression (PD): A multicenter phase II trial, SAKK 19/05.Francesco Zappa, Miklos Pless, C. Droege et al.|Journal of Clinical Oncology|2011Cited by 3